FDA Panel Gets Varied Opinions on DTC Genomics | GenomeWeb

By a GenomeWeb Staff Reporter

NEW YORK (GenomeWeb News) – Advisers for the US Food and Drug Administration this week heard arguments and recommendations about how it should approach direct-to-consumer genetic testing, with some parties making the case for little or no regulation, others seeking tighter controls, and some proposing a stratified regulatory scheme.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: genes involved in histone deacetylation in Arabidopsis, effects of pathogenic presenilin-1 mutations, and more.

After a study finds DNA from antibiotic-resistant bacteria in Beijing smog, residents there worry, according to the New York Times.

Canada begins its search for a chief government science advisor, Nature News reports.

A company is using facial recognition tools to identify genetic disorders from pictures, Technology Review reports.